Loading clinical trials...
Loading clinical trials...
A Phase 2 Study of MEDI-575 in Adult Subjects With Recurrent Glioblastoma Multiforme
Conditions
Interventions
MEDI-575
Locations
12
United States
Research Site
Tucson, Arizona, United States
Research Site
Los Angeles, California, United States
Research Site
Stanford, California, United States
Research Site
Chicago, Illinois, United States
Research Site
Boston, Massachusetts, United States
Research Site
Detroit, Michigan, United States
Start Date
January 1, 2011
Primary Completion Date
November 1, 2012
Completion Date
November 1, 2012
Last Updated
April 6, 2017
NCT00083512
NCT05839379
NCT07100730
NCT05281731
NCT07391215
NCT05756985
Lead Sponsor
MedImmune LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions